학술논문

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers
Document Type
Article
Source
In: PLoS ONE. (PLoS ONE, May 2021, 16(5 May))
Subject
Language
English
ISSN
19326203